Eli Lilly (LLY) news
Recent news
S&P 500 down 0.27%, Dow dips 0.07%
On Tuesday, August 28, 2026, the S&P 500 closed down 0.27% at 6,606.76, while the Dow Jones Industrial Average fell 125.55 points, or 0.27%, to 45,757.90. The Nasdaq Composite also declined, shedding 0.07% to 22,333.96. The market’s modest losses came as investors took profits ahead of the Federal…
AInvest Wire · 7h agoImportantL Lilly diabetes shot Mounaro wins FDA nod for heart disease
AInvest Wire · 14h agoNexera Pharma Co., - Milestone payment expected to be recognized as revenue in Q3 FY2026
Nxera Pharma (TSE: 4565) reported continued progress in its partnered programs and commercial activities during the second quarter of FY2026, with several key developments expected to contribute to revenue in the coming quarters. The company highlighted that it has achieved multiple milestones…
AInvest Wire · 2d agoImportantEli Lilly (LLY) shares rose 4.59% during intraday trading as the broader weight-loss drug sector gained momentum
AInvest Wire · Aug 19, 2026ImportantAlzecure receives a USD 10 million upfront payment and completes initial transaction with Lilly
AInvest Wire · Aug 18, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.